Advertisement

Topics

New Anticoagulation Strategies of VV-ECMO

2018-04-20 09:47:10 | BioPortfolio

Published on BioPortfolio: 2018-04-20T09:47:10-0400

Clinical Trials [330 Associated Clinical Trials listed on BioPortfolio]

Safety of a Diagnostic Strategy With D-Dimer Testing for PE

To determine whether D-Dimer testing, using the MDA D-Dimer assay, can be used to simplify the diagnostic process for pulmonary embolism (PE). This will be assessed by performing a cohort...

Accuracy of the D-Dimer Assay for the Exclusion of Pulmonary Embolism in a High Risk Oncologic Population

The purpose of this study is to see if a blood test (D-dimer) is as precise as the CT scan for the detection of clots. A pulmonary embolism is an obstruction of the blood vessels in your ...

D-Dimer to Predict Recurrence in Patients With Multiple Episodes of Venous Thromboembolism

Optimal duration of oral anticoagulant therapy in patients with recurrent episodes of venous thromboembolism (VTE) is a matter of debate and recommendations are based on inadequate evidenc...

Comparison Between Point of Care International Normalized Ratio (INR) and Activated Partial Thromboplastin Time (aPTT) Hemochron Jr Whole Blood Measurement With Standard Laboratory

The purpose of this study is determine the agreement of point of care (POC) clotting tests (INR and aPTT) by the POC device by Hemochron Jr versus standard laboratory clotting tests (INR a...

D-dimer to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months

The purpose of this study is to determine if the risk of recurrent venous thromboembolism (VTE) after stopping therapy is low and acceptable in patients with a first unprovoked proximal de...

PubMed Articles [1102 Associated PubMed Articles listed on BioPortfolio]

The Clinical Value of D-dimer level in Patients with Non-aneurysmal Subarachnoid Hemorrhage.

A growing number of non-aneurysmal subarachnoid hemorrhage (NaSAH) were found in clinical practice. However, the precise mechanisms in which D-dimer level is associated with clinical condition in pati...

Hemostatic Abnormalities in Multiple Myeloma Patients

Background: Multiple myeloma (MM) is a neoplastic plasma cell disorder characterized by clonal proliferation of plasma cells in the bone marrow. Diverse hemostatic abnormalities have been reported in ...

Hyperfibrinolysis Is an Important Cause of Early Hemorrhage in Patients with Acute Promyelocytic Leukemia.

BACKGROUND The objective of the current study was to guide the early clinical treatment strategies by assessing the recovery of abnormal coagulation in acute promyelocytic leukemia (APL) patients duri...

Activated partial thromboplastin time derivative curves: helpful diagnostic tool in mixing test interpretation.

: The mixing test is used to evaluate whether prolonged activated partial thromboplastin time (APTT) is due to an inhibitor or a factor deficiency. The coagulation reaction is demonstrated with APTT d...

Age-adjusted versus clinical probability-adjusted D-dimer to exclude pulmonary embolism.

A low D-dimer can exclude suspected pulmonary embolism (PE) in cases with low or intermediate clinical probability of disease. Yet D-dimer is nonspecific, so many cases without PE require imaging. D-d...

Medical and Biotech [MESH] Definitions

Natural recurring desire for food. Alterations may induced by APPETITE DEPRESSANTS or APPETITE STIMULANTS.

Hemorrhage within the orbital cavity, posterior to the eyeball.

Intraocular hemorrhage from the vessels of various tissues of the eye.

A homodimerization protein interaction domain occurring at the N terminus of proteins that contain multiple copies of either CYS2-HIS2 ZINC FINGERS or KELCH REPEATS. It is characterized by a tightly intertwined dimer with an extensive hydrophobic interface. A surface-exposed groove lined with conserved amino acids is formed at the dimer interface, suggesting a peptide-binding site. Many BTB proteins are transcriptional regulators that are thought to regulate CHROMATIN structure.

Hemorrhage following any surgical procedure. It may be immediate or delayed and is not restricted to the surgical wound.

More From BioPortfolio on "New Anticoagulation Strategies of VV-ECMO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial